Advertisement
Screener

PRECISION BIOSCIENCES INC (DTIL) Total Long-Term Debt

2.8 / 5 stars · 68/120 Roast Me

PRECISION BIOSCIENCES INC Total Long-Term Debt

PRECISION BIOSCIENCES INC (DTIL) had Total Long-Term Debt of $22.27 million as of 2023-03-31, per its 10-Q filed 2023-05-09.

Discontinued › Balance Sheet › Liabilities

us-gaap:LongTermDebt · last filed 2024-03-27

  • 2023-03-31: Long-term Debt $22.27M.
  • 2022-12-31: Long-term Debt $22.22M.
  • 2022-09-30: Long-term Debt $22.17M.
  • 2022-06-30: Long-term Debt $22.12M.
Period endLong-term Debt
2023-03-31$22.27M
10-Q · filed 2023-05-09
2022-12-31$22.22M
10-K · filed 2024-03-27
2022-09-30$22.17M
10-Q · filed 2022-11-08
2022-06-30$22.12M
10-Q · filed 2022-08-08
2022-03-31$2.48M
10-Q · filed 2022-05-09
2021-12-31$2.48M
10-K · filed 2023-03-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
Alector, Inc. (ALEC)United States$0.213B-1.90